Andrew Moon
@AndrewMMoon
Hepatologist and researcher at @UNCGastro, @UNCLiverCenter and @UNC_Lineberger w/ focus on #LiverCancer | @AmJGastro Deputy AE | opinions mine alone
FIB-4 Score in Young Healthy Adults and Its Association with End Stage Liver Disease: A Nationwide Retrospective Study Meron, et al. 📕 doi.org/10.14309/ajg.0… @gilbenyakov @KarpatiTomas @MLongMD @JasmohanBajaj
Use Fibroscan liver stiffness + platelet count to document: ➡Clinically Significant Portal Hypertension (CSPH) ➡compensated Advanced Chronic Liver Disease (cACLD) Our Hepatology📰 shows the categories & rationale & argues for category of "critical" CSPH journals.lww.com/hep/fulltext/2…
Long-term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results Levy, et al. 📕 doi.org/10.14309/ajg.0… @DrCynthiaLevy @CholestasisDoc @clbowlus @macarlotal @DrAliyaMD @kremer_andreas @MLongMD @JasmohanBajaj
Traditional Serrated Adenomas Associated with Risk of Subsequent High-Risk Polyps and Colorectal Cancer Chen, et al. 📕 doi.org/10.14309/ajg.0… @shen_jiaxian @YujiaLuYL @MingyangSong3 @MLongMD @JasmohanBajaj
Incredible news! #LR5 (Definite #HCC) criteria of #LIRADS, including #CEUS, are now fully aligned with #OPTN #liver #transplant @UNOSNews @RadiologyACR @chemshift1 optn.transplant.hrsa.gov/media/ojdh4qi1…
New this year: 3 internal medicine residents were selected as the 1st ACG Case Reports Journal Social Media Ambassadors. Dr. Harsimran Kalsi leads the team, with support from Dr. Aya Akhras and Dr. Taha Bin Arif. Welcome! @DrHSKalsi @Ayaakhras_ @TahaBinArifMD
Welcome, 2025-2026 ACG Case Reports Journal Associate Editors! #GIfellows @hassamalii @KAlsabb @Ansari_Zaid7 @AasthaBharwad @Chatterjee_MD @umer446 @fouadsjaber @AbelJosephMD @RahulKarnaMD @FaisalNimri3 @SanjeevaniTomar
🆕 ACG 2025 IBD Preventive Care 🦠 Vaccines ▪️PCV 20/21 for all adults ▪️Zoster ≥19 if suppressed ▪️Flu q1y (high dose ≥65) ▪️HBV if non-immune ▪️RSV ≥60 if risk factors 🧬 Cancer ▪️Cervical: if immunotherapy ▪️Skin: q1y, esp if on thiopurines/JAKs 🔗bit.ly/acg-ibd-preven…
The July issue of the #RedJournal is here! Explore this month's articles, including a new ACG Clinical Guideline: Preventive Care in IBD! 📕 amjgastro.com @MLongMD @JasmohanBajaj @FarrayeIBD @dr_fcalderaibd @GilMelmedMD @EdBarnesMD @berkeleydoc @SunandaKaneMD
Final board meeting of the term @ACGCRJ Proud of this stellar team who set a new bar for excellence!🙌 ✅Achieved beyond their term🎯 🌟Reviewed record submissions ⏰Shorter decision time 📈 Boost journal visibility 🤝 Mentored with committees 🙏 @AmCollegeGastro @PrateekHarne1
Finally read this study @AmJGastro @AmCollegeGastro @JasmohanBajaj ▶️RCT, FMT v PCB x 8 wks ▶️baseline SES-CDs ~12-15 ▶️well designed 🔴trial stopped; futility 🟢👏to @AmJGastro & authors for the study! 🔘anyone surprised? I’d love to hear thoughts journals.lww.com/ajg/fulltext/2…
.@AmJGastro has released updated #ClinicalGuidelines for managing #CrohnsDisease, balancing the latest evidence with patient-centered care. As incidence rises, flexible, individualized approaches are key to improving outcomes. journals.lww.com/ajg/fulltext/2…
Prospective Evaluation of Opioid Cessation in Patients With Suspected Opioid-Induced Esophageal Dysfunction Ezquerra-Durán & Alcalá-González, et al. 📕 bit.ly/44n9DjD @MLongMD @JasmohanBajaj @93Ezquerra @alcala_glez_LG @ikaraujoa @alcedo_javier @jordiserradr
🤔 Data in @AmJGastro showed that fecal microbiota transplantation is not effective at inducing clinical or endoscopic remission in patients with #Crohnsdisease, but is there more do investigate? Healio spoke with a researcher from @UAlberta 👇 bit.ly/4lfGWL6
New study in @AmJGastro using national & global databases reveals trends in GI and liver cancers Recent declines but most GI cancers to rise in incidence from 2020 to 2040, especially in men. 📈 #CancerResearch Link: journals.lww.com/ajg/fulltext/2…
Most #IBS drug studies focus on what works. But what about harm? We analyzed 54 clinical trials to calculate number needed to harm (NNH) for common IBS meds 🔍 Key: - Rifaximin=safest - Tricyclics, alosetron, tenapanor=highest risk - NNH + NNT=better patient-centered decisions…
New! ACG Clinical Guideline Update on Ulcerative Colitis Rubin, et al. 📕 bit.ly/acg-uc-2025 @JasmohanBajaj @MLongMD @IBDMD @DrCoreySiegel @EdBarnesMD #IBD
Great new @AmCollegeGastro Guideline Highlights summarizing some key points on diagnosis and management of focal liver lesions Guideline: journals.lww.com/ajg/fulltext/2…
Proud to share this ACG guideline highlights of focal liver lesions. Great work by the guideline authors and ACG publication team and committee @AndrewMMoon @Robert_J_Wong @AmJGastro @AmCollegeGastro
Feeling such gratitude for the 🔥team effort by the @AmCollegeGastro #Institute staff, our course directors & inspirational faculty that made it possible to run 4 simultaneous targeted programs, one combined program & of course, iconic speed networking! WOW🥊
What an incredible weekend! Congratulations @NeenaSAbrahamMD on a resoundingly successful Leadership YOU event!!